Enzo Biochem (ENZ)
0.2910 x 58 0.4000 x 50
Post-market by (Cboe BZX)
0.3138 -0.0678 (-17.77%) 04/17/25 [NYSE]
0.2910 x 58 0.4000 x 50
Post-market 0.3138 unch (unch) 19:00 ET
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ENZ | SABS | CRIS | ||
| Company | Enzo Biochem | Sab Biotherapeutics Inc | Curis Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 0.3702 | 1.7100 | 1.6500 | ||
| High | 0.4000 | 1.8100 | 1.8900 | ||
| Low | 0.3138 | 1.6420 | 1.6500 | ||
| Last | 0.3138 | 1.7899 | 1.8600 | ||
| Change | -0.0678 | +0.0399 | +0.2300 | ||
| % Change | -17.77% | +2.28% | +14.11% | ||
| Volume | 4,123,800 | 32,700 | 101,000 | ||
| 20-Day Average Volume | 625,155 | 27,930 | 109,490 | ||
| Previous Close | 0.3816 | 1.7500 | 1.6300 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3655 | 1.3411 | 1.3985 | ||
| 20-Day Raw Stochastic | 23.06% | 97.52% | 62.69% | ||
| 20-Day Relative Strength | 38.95% | 56.79% | 47.34% | ||
| Weighted Alpha | -71.03 | -41.64 | -81.62 | ||
| Today's Opinion | 100% Sell | 56% Sell | 88% Sell | ||
| Previous Opinion | 88% Sell | 64% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +20.32% since 04/10/25 | +25.53% since 04/21/25 | +43.08% since 04/21/25 | ||
| Low | 0.2860 on 04/11/25 | 1.3000 on 04/22/25 | 1.3000 on 04/22/25 | ||
| High | 0.4190 on 04/16/25 | 1.8100 on 04/28/25 | 1.8900 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -33.25% since 03/17/25 | +20.94% since 03/28/25 | -19.83% since 03/28/25 | ||
| Low | 0.2520 on 04/04/25 | 1.0000 on 04/04/25 | 1.0200 on 04/09/25 | ||
| High | 0.5344 on 03/19/25 | 1.8100 on 04/28/25 | 2.3600 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -52.09% since 01/17/25 | -13.53% since 01/28/25 | -40.58% since 01/28/25 | ||
| Low | 0.2520 on 04/04/25 | 1.0000 on 04/04/25 | 1.0200 on 04/09/25 | ||
| High | 0.6868 on 01/22/25 | 2.6500 on 01/29/25 | 3.5699 on 02/03/25 | ||
| 6-Month | |||||
| %Chg | -72.23% since 10/17/24 | -38.70% since 10/28/24 | -62.20% since 10/28/24 | ||
| Low | 0.2520 on 04/04/25 | 1.0000 on 04/04/25 | 1.0200 on 04/09/25 | ||
| High | 1.1900 on 10/30/24 | 5.0100 on 12/09/24 | 5.0000 on 11/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,444 | 16,626 | 15,787 | ||
| Shares Outstanding, K | 52,403 | 9,289 | 8,488 | ||
| Annual Sales | 31,910,000 | 1,320,000 | 10,910,000 | ||
| Annual Net Income | -26,080,000 | -34,110,000 | -43,390,000 | ||
| Last Quarter Sales | 7,330,000 | 110,000 | 3,350,000 | ||
| Last Quarter Net Income | -1,540,000 | -11,390,000 | -9,620,000 | ||
| 60-Month Beta | 1.19 | 0.52 | 3.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/17/25 | -1.23 on 03/28/25 | -1.25 on 03/31/25 | ||
| Latest Earnings Date | 06/12/25 | 05/19/25 | 05/06/25 | ||
| Most Recent Dividend | 0.100 on 11/15/24 | N/A | N/A | ||
| Next Ex-Dividends Date | 11/15/24 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||